Almirall, LLC et al v. Taro Pharmaceuticals, Inc.
| Delaware District Court | |
| Case #: | 1:25-cv-00385 |
| Nature of Suit | 835 Property Rights - Patent – Abbreviated New Drug Application |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Mar 28, 2025 |
| Last checked: Friday Mar 28, 2025 3:15 PM EDT |
|
Defendant
Taro Pharmaceuticals, Inc.
|
|
|
Plaintiff
ATNX SPV, LLC
|
Represented By
|
|
Plaintiff
Almirall, LLC
|
Represented By
|
|
Plaintiff
Almirall, S.A.
|
Represented By
|
| Docket last updated: 03/30/2025 11:59 PM EDT |
| Friday, March 28, 2025 | ||
| 6 | 6
service
Summons Issued
Fri 03/28 2:45 PM
Summons Issued as to Taro Pharmaceuticals, Inc. on 3/28/2025. (jfm) |
|
| 5 | 5
misc
Disclosure Statement - Rule 7.1
Fri 03/28 2:44 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sagard Healthcare Royalty Partners, LP for ATNX SPV, LLC; Other Affiliate Almirall, S.A. for Almirall, LLC - filed by ATNX SPV, LLC, Almirall, LLC, Almirall, S.A. (jfm) |
|
| 4 | 4
misc
Patent/Trademark Report to Commissioner of Patents
Fri 03/28 2:41 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,300,931 B2; 7,851,470 B2; 10,323,001 B2; 10,617,693 B2 ; 10,669,236 B2; 11,497,750 B2. (jfm) |
|
| 3 | 3
misc
ANDA Form
Fri 03/28 2:40 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/15/2025. Date of Expiration of Patent: U.S. Patent No. 7,300,931 will expire on 02/06/2026; U.S. Patent No. 7,851,470 will expire on 02/02/2029; U.S. Patent No. 10,323,001 will expire on 12/28/2027; U.S. Patent No. 0,617,693 will expire on 03/12/2038; U.S. Patent No. 10,669,236 will expire on 09/07/2038; U.S. Patent No. 11,497,750 will expire on 03/12/2038. Thirty Month Stay Deadline: 6/14/2028. (jfm) |
|
| 2 | 2
misc
Magistrate Consent Forms
Fri 03/28 2:37 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
|
| 1 | 1
12
pgs
cmp
Complaint
Fri 03/28 2:37 PM
COMPLAINT for Patent Infringement against Taro Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4648665) - filed by Almirall, S.A., Almirall, LLC, ATNX SPV, LLC.(jfm) |
|
|
Att: 1
Exhibits A-F,
|
||
|
Att: 2
Civil Cover Sheet
|
||